ATE446383T1 - Verfahren und zusammensetzungen zur herstellung und verwendung fixiert behandelter zellinien und von fixiert behandeltem gewebe bei der in-situ- fluoreszenzhybridisierung - Google Patents

Verfahren und zusammensetzungen zur herstellung und verwendung fixiert behandelter zellinien und von fixiert behandeltem gewebe bei der in-situ- fluoreszenzhybridisierung

Info

Publication number
ATE446383T1
ATE446383T1 AT04778619T AT04778619T ATE446383T1 AT E446383 T1 ATE446383 T1 AT E446383T1 AT 04778619 T AT04778619 T AT 04778619T AT 04778619 T AT04778619 T AT 04778619T AT E446383 T1 ATE446383 T1 AT E446383T1
Authority
AT
Austria
Prior art keywords
fixed
tissue
methods
treated
compositions
Prior art date
Application number
AT04778619T
Other languages
English (en)
Inventor
Jon Edelson
Paola Capodieci
Original Assignee
Aureon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aureon Lab Inc filed Critical Aureon Lab Inc
Application granted granted Critical
Publication of ATE446383T1 publication Critical patent/ATE446383T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
AT04778619T 2003-07-21 2004-07-19 Verfahren und zusammensetzungen zur herstellung und verwendung fixiert behandelter zellinien und von fixiert behandeltem gewebe bei der in-situ- fluoreszenzhybridisierung ATE446383T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/624,233 US6995020B2 (en) 2003-07-21 2003-07-21 Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization
PCT/US2004/023207 WO2005010203A2 (en) 2003-07-21 2004-07-19 Treatment of cells for fluorescence in situ hybridization

Publications (1)

Publication Number Publication Date
ATE446383T1 true ATE446383T1 (de) 2009-11-15

Family

ID=34079958

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04778619T ATE446383T1 (de) 2003-07-21 2004-07-19 Verfahren und zusammensetzungen zur herstellung und verwendung fixiert behandelter zellinien und von fixiert behandeltem gewebe bei der in-situ- fluoreszenzhybridisierung

Country Status (7)

Country Link
US (2) US6995020B2 (de)
EP (1) EP1689883B1 (de)
AT (1) ATE446383T1 (de)
AU (1) AU2004260105A1 (de)
CA (1) CA2532467C (de)
DE (1) DE602004023753D1 (de)
WO (1) WO2005010203A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8062897B2 (en) * 2003-07-21 2011-11-22 Aureon Laboratories, Inc. Diagnostic histopathology using multiplex gene expression FISH
US7467119B2 (en) * 2003-07-21 2008-12-16 Aureon Laboratories, Inc. Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
US6995020B2 (en) * 2003-07-21 2006-02-07 Aureon Laboratories, Inc. Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization
WO2005086068A2 (en) * 2004-02-27 2005-09-15 Aureon Laboratories, Inc. Methods and systems for predicting occurrence of an event
DK2500439T4 (da) * 2005-06-20 2017-11-13 Advanced Cell Diagnostics Inc Kits og produkter til detektering af nukleinsyrer i individuelle celler og til identifikation af sjældne celler fra store heterogene cellepopulationer
US7599893B2 (en) * 2005-10-13 2009-10-06 Aureon Laboratories, Inc. Methods and systems for feature selection in machine learning based on feature contribution and model fitness
PT1934607E (pt) * 2005-10-13 2013-11-13 Fundacao D Anna Sommer Champalimaud E Dr Carlos Montez Champalimaud Análise imuno-histoquímica in situ multiplex
WO2007117700A2 (en) 2006-04-07 2007-10-18 The Trustees Of The University Of Pennsylvania In situ cloning from pathological tissue specimens
US8131476B2 (en) * 2006-08-07 2012-03-06 General Electric Company System and method for co-registering multi-channel images of a tissue micro array
US20080032321A1 (en) * 2006-08-07 2008-02-07 General Electric Company System and methods for analyzing images of tissue samples
US8060348B2 (en) * 2006-08-07 2011-11-15 General Electric Company Systems for analyzing tissue samples
US9779213B2 (en) 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
ES2795036T3 (es) * 2008-07-25 2020-11-20 Fund D Anna Sommer Champalimaud E Dr Carlos Montez Champalimaud Sistemas y métodos para tratar, diagnosticar y predecir la aparición de una afección médica
US20100081928A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological Facilitation systems and methods
US20100081924A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081915A1 (en) * 2008-09-29 2010-04-01 Searete Llc, Alimited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081927A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081916A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Histological facilitation systems and methods
US20100081926A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081131A1 (en) * 2008-10-01 2010-04-01 Ach Robert A Identification of microbes using oligonucleotide based in situ hybridization
WO2010065775A2 (en) * 2008-12-03 2010-06-10 The United States Government As Represented By The Department Of Veterans Affairs Pressure-assisted molecular recovery (pamr) of biomolecules, pressure-assisted antigen retrieval (paar), and pressure-assisted tissue histology (path)
CA3010836C (en) 2010-07-30 2020-09-08 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud Systems and methods for segmentation and processing of tissue images and feature extraction from same for treating, diagnosing, or predicting medical conditions
DK2625502T3 (en) 2010-10-06 2018-12-17 Biocare Medical Llc Method and system for efficient processing of biological samples
US9945763B1 (en) 2011-02-18 2018-04-17 Biocare Medical, Llc Methods and systems for immunohistochemistry heat retrieval of biological samples
CN104145027A (zh) * 2011-12-12 2014-11-12 塞雷公司 用于室温原位检测生物样品中的目标核酸的方法和试剂盒
US9278401B2 (en) * 2013-02-11 2016-03-08 International Business Machines Corporation Fill head interface with combination vacuum pressure chamber
EP3174993B1 (de) 2014-07-30 2023-12-06 President and Fellows of Harvard College Konstruktion einer sondenbibliothek
US11078528B2 (en) 2015-10-12 2021-08-03 Advanced Cell Diagnostics, Inc. In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
KR20180100607A (ko) * 2016-01-07 2018-09-11 크리에티브이 마이크로테크, 인크. 순차적인 형광 소광 및 재염색을 이용한 생물학적 시료의 다중-표현형적 서브타이핑
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN112368705A (zh) * 2018-05-24 2021-02-12 匹兹堡大学高等教育联邦体系 从空间多参数细胞和亚细胞成像数据预测癌症复发
CN109035415B (zh) * 2018-07-03 2023-05-16 百度在线网络技术（北京）有限公司 虚拟模型的处理方法、装置、设备和计算机可读存储介质
CN110208056B (zh) * 2019-06-06 2021-08-31 厦门大学附属第一医院 胃癌her-2 fish的组织芯片制作方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024933A (en) * 1988-05-10 1991-06-18 Enzo Biochem, Inc. Method and kit for sample adherence to test substrate
US6699710B1 (en) 1998-02-25 2004-03-02 The United States Of America As Represented By The Department Of Health And Human Services Tumor tissue microarrays for rapid molecular profiling
US6544798B1 (en) * 1999-02-26 2003-04-08 Ventana Medical Systems, Inc. Removal of embedding media from biological samples and cell conditioning on automated staining instruments
US6534266B1 (en) 1999-04-22 2003-03-18 Albert Einstein College Of Medicine Of Yeshiva University Assay of transcription sites by multi-fluor fish
US20030017491A1 (en) * 2000-09-14 2003-01-23 Zuo-Rong Shi Chromogenic in situ hybridization methods, kits, and compositions
DE10061655A1 (de) * 2000-12-11 2002-06-20 Vermicon Ag In situ-Hybridisierungs-Anordnung zum spezifischen Nachweis von Mikroorganismen
US6696271B2 (en) 2001-08-23 2004-02-24 The Regents Of The University Of California Frozen tissue microarray technology for analysis of RNA, DNA, and proteins
US6924102B2 (en) * 2001-08-24 2005-08-02 Huynh Mai Thi Nguyen Utilization of nucleotide probes for the measurement of specific mRNA for the molecular diagnosis of autosomal recessive spinal muscular atrophy
US6580056B1 (en) 2001-09-21 2003-06-17 Biocare Medical Biological specimen heating device and quality control method for immunohistochemistry heat retrieval procedures
US6995020B2 (en) * 2003-07-21 2006-02-07 Aureon Laboratories, Inc. Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization

Also Published As

Publication number Publication date
EP1689883A4 (de) 2007-10-10
US20050019779A1 (en) 2005-01-27
US20060141502A1 (en) 2006-06-29
EP1689883A2 (de) 2006-08-16
US7326575B2 (en) 2008-02-05
AU2004260105A1 (en) 2005-02-03
WO2005010203A2 (en) 2005-02-03
CA2532467A1 (en) 2005-02-03
CA2532467C (en) 2011-03-22
DE602004023753D1 (de) 2009-12-03
US6995020B2 (en) 2006-02-07
EP1689883B1 (de) 2009-10-21
WO2005010203A3 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
ATE446383T1 (de) Verfahren und zusammensetzungen zur herstellung und verwendung fixiert behandelter zellinien und von fixiert behandeltem gewebe bei der in-situ- fluoreszenzhybridisierung
CY1125130T1 (el) Ανταγωνιστες c5ar
ATE523786T1 (de) In-vitro-verfahren zur prognose des fortschreitens einer krebserkrankung und des ausgangs für einen patienten sowie verfahren zur durchführung des verfahrens
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
ATE483032T1 (de) Verfahren zur herstellung von oligonukleotiden
DE60328618D1 (de) Verfahren für die behandlung von proliferativen erkrankungen von brustzellen
ATE321088T1 (de) Polysiloxanpolymere, verfahren zu ihrer herstellung und ihre verwendung
DE602004017426D1 (de) Benutzung von intronischen rna sequenzen zur quantifizierung der genexpression
DE602004030372D1 (de) Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
DE112005001530T5 (de) Verfahren zur Spektralidentifikation von Mikroorganismen
ATE437906T1 (de) Verfahren zur herstellung von pfropfpolymerisaten
ATE528356T1 (de) Anorganisch-modifizierte polyesterbindemittelzubereitung, verfahren zur herstellung und ihre verwendung
ATE356136T1 (de) Verfahren zur herstellung von 1,2- diaminocyclohexan-platin(ii)-komplexen
ATE414277T1 (de) Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen
DE60335812D1 (de) Biosensor und verfahren zu seiner herstellung
DE50207332D1 (de) Phosphonite, ihre verwendung als ligand in übergangsmetall komplexen und verfahren zur herstellung von nitrilen
DE60326748D1 (de) Verfahren zur identifizierung des brustkrebsrisikos
ATE480265T1 (de) Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen
DE602006009901D1 (de) Verfahren zur herstellung von 7-ethyl-10-hydroxycamptothecin
WO2009086000A3 (en) Biomarkers for trichogenicity
DE502005004235D1 (de) Verfahren zur Herstellung von Durchzügen in Sammelrohren und Vorrichtung zur Durchführung des Verfahrens
DE502004012314D1 (de) Verfahren zum reaktiv-färben von leder, sowie farbstoffe und deren verwendung
ATE487730T1 (de) Verfahren zur herstellung eines oxaliplatins
HK1086591A1 (en) Crystalline vap-1 and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties